Cyclophosphamide Drug Interaction Study In Cancer Patients

NCT00334646 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

25

Enrollment

INDUSTRY

Sponsor class

Stopped compound terminated

Conditions

Nausea and Vomiting, Chemotherapy-Induced

Interventions

DRUG: Oral GW679769
DRUG: IV Cyclophosphamide 500-700mg/m2

Sponsor

GlaxoSmithKline